does retatrutide make you poop Diarrhea: Rates, Causes & Management Unapproved weight loss drug retatrutide

GLP-1 RAs may address this directly Tirzepatide (dual GIP/GLP-1) appears to achieve the greatest weight reduction (1624% in non-diabetic patients) GLP-1 RAs may reduce or enable tapering of systemic immunosuppressants (including methotrexate and biologics) in patients who achieve significant weight loss, reducing cumulative toxicity

doi: 10.1046/j.1464-5491.2001.00424.x 26 KendallDMRiddleMCRosenstockJZhuangDKimDDFinemanMSet al

If nausea or other gastrointestinal effects persist beyond 4-6 weeks despite a stable dose, the post directs readers back to their provider rather than to any self-managed change

Medication Options and Costs Calibrate only offers name-brand, FDA-approved GLP-1s

Discordance between central (brain) and pancreatic action of Exenatide in lean and obese subjects

They're not